Publications by authors named "Cristina Knape"
Background: COVID-19 Convalescent plasma (CCP) is safe and effective, particularly if given at an early stage of the disease. Our study aimed to identify an association between survival and specific antibodies found in CCP.
Patients And Methods: Patients ≥18 years of age who were hospitalized with moderate to severe COVID-19 infection and received CCP at the MD Anderson Cancer Center between 4/30/2020 and 8/20/2020 were included in the study.
Background: COVID-19 Convalescent plasma (CCP) is safe and effective, particularly if given at an early stage of the disease. Our study aimed to identify an association between survival and specific antibodies found in CCP.
Patients And Methods: Patients ≥18 years of age who were hospitalized with moderate to severe COVID-19 infection and received CCP at the MD Anderson Cancer Center between 4/30/2020 and 8/20/2020 were included in the study.
Article Synopsis
- Immune checkpoint inhibitors (ICIs) are being explored for use after allogeneic hematopoietic stem cell transplantation (alloHCT) to address immune dysfunction, but they may increase the risk of graft-versus-host disease (GVHD).
- A study involving 21 patients with relapsed acute myeloid leukemia or myelodysplastic syndromes found that the type of GVHD prophylaxis significantly influenced the incidence of acute GVHD following ICI therapy.
- Patients who received post-transplantation cyclophosphamide (PTCy) had a shorter median time to start ICI therapy and a notably lower risk of developing acute GVHD compared to those who did not receive PTCy, suggesting PTCy may